Blood News and Research

RSS

Researchers decipher how the immune system memorizes pathogens after an infection

The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen. Now, scientists at the University of Würzburg have deciphered new details of this process.

28 Sep 2020

Study finds new treatment approach for patients with salt sensitive hypertension

High blood pressure (hypertension) affects one in two U.S. adults and can cause hardening and thickening of the arteries (atherosclerosis), which can lead to heart attacks, strokes or other complications including chronic kidney disease.

28 Sep 2020

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.

28 Sep 2020

NCCN publishes new clinical practice guidelines for pediatric Hodgkin lymphoma

The National Comprehensive Cancer Network today announced the publication of new NCCN Clinical Practice Guidelines in Oncology for Pediatric Hodgkin Lymphoma. Hodgkin lymphoma is one of the most curable forms of pediatric cancer, with long-term survival rates of 90% or higher.

28 Sep 2020

Study finds identical signs of brain damage in sleep apnea and Alzheimer's disease

New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.

28 Sep 2020

Researchers study placebo effect in nausea treatment at the molecular level

The molecular bases of the placebo effect are poorly understood. A team led by Ludwig-Maximilians-Universitaet in Munich researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact.

28 Sep 2020

Marrowquant can quantify multiple bone components in histological images

The bone marrow is the soft tissue inside our bones. Its main role is to produce stem cells that will go on to become various cells of the blood, including white blood cells that fight infections, red blood cells that carry oxygen throughout the body, and platelets that control bleeding.

28 Sep 2020

Newer Type 2 diabetes medications could reduce kidney, heart disease risks

Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.

28 Sep 2020

Study identifies genes linked with abdominal aortic aneurysm

A veteran's study identified more than a dozen genes associated with abdominal aortic aneurysm (AAA) that could be used to better identify people at risk for the often-deadly condition, according to new research published today in the American Heart Association's flagship journal Circulation.

28 Sep 2020

Study may explain why hormone therapy slows progression of heart disease

As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis.

28 Sep 2020

Risk factors for mortality among hospitalized patients with COVID-19

A new study by scientists at biotechnology company Genentech, Inc., and published on the preprint server medRxiv in September 2020 attempts to identify the factors which may shape the risk for death in COVID-19 disease.

27 Sep 2020

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.

27 Sep 2020

ECMO appears to be saving the lives of many critically ill COVID-19 patients

It saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing the same for many of the critically ill COVID-19 patients who receive it, according to a new international study.

26 Sep 2020

WHO plans to increase access to affordable, quality-assured testing and treatment for diabetes

Over a four-day workshop that ended on 25 September 2020, WHO and key international health partners mapped out a plan to boost access to affordable and quality-assured testing and treatment for diabetes.

26 Sep 2020

Pitt team receives NIH award to optimize tissue-engineered vascular graft design

Just as a climbing plant needs the right trellis to thrive, a small-diameter tissue-engineered vascular graft (TEVG) needs the right scaffold to transform seeded cells into a native-like artery that can save a life.

25 Sep 2020

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.

25 Sep 2020

Study verifies the link between cramps and muscle damage in marathon events

This is the first research to verify, in marathon events, the link between cramps and muscle damage suffered during the race and not dehydration.

25 Sep 2020

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

25 Sep 2020

Novel technique helps detect heart damage in top-level competition dogs

Frequent high-intensity exercise entails cardiac remodelling both in humans and animals. In dogs, especially those used for top-level competition, it is of great interest to learn whether they develop the so-called athletic heart syndrome.

25 Sep 2020

Patients with severe COVID-19 have antibodies blocking body's important defense mechanisms

Persons with critical corona-disease may have antibodies blocking the body´s most important defence mechanisms.

25 Sep 2020

Blood News and Research

Researchers decipher how the immune system memorizes pathogens after an infection

Study finds new treatment approach for patients with salt sensitive hypertension

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

NCCN publishes new clinical practice guidelines for pediatric Hodgkin lymphoma

Study finds identical signs of brain damage in sleep apnea and Alzheimer's disease

Researchers study placebo effect in nausea treatment at the molecular level

Marrowquant can quantify multiple bone components in histological images

Newer Type 2 diabetes medications could reduce kidney, heart disease risks

Study identifies genes linked with abdominal aortic aneurysm

Study may explain why hormone therapy slows progression of heart disease

Risk factors for mortality among hospitalized patients with COVID-19

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

ECMO appears to be saving the lives of many critically ill COVID-19 patients

WHO plans to increase access to affordable, quality-assured testing and treatment for diabetes

Pitt team receives NIH award to optimize tissue-engineered vascular graft design

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

Study verifies the link between cramps and muscle damage in marathon events

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Novel technique helps detect heart damage in top-level competition dogs

Patients with severe COVID-19 have antibodies blocking body's important defense mechanisms

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News